|Publication number||US20050214865 A1|
|Application number||US 11/063,408|
|Publication date||Sep 29, 2005|
|Filing date||Feb 23, 2005|
|Priority date||Feb 14, 1997|
|Also published as||EP1151294A1, US6514461, US6716393, US6964752, US7537733, US7943381, US8202729, US8455257, US9018015, US20020081233, US20040166023, US20050074362, US20070048184, US20070048875, US20070298436, US20110208438, US20120284054, US20130268450, US20150227777, WO2000046598A1|
|Publication number||063408, 11063408, US 2005/0214865 A1, US 2005/214865 A1, US 20050214865 A1, US 20050214865A1, US 2005214865 A1, US 2005214865A1, US-A1-20050214865, US-A1-2005214865, US2005/0214865A1, US2005/214865A1, US20050214865 A1, US20050214865A1, US2005214865 A1, US2005214865A1|
|Original Assignee||Murray Lappe|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (72), Referenced by (3), Classifications (59), Legal Events (2)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application is a continuation of U.S. application Ser. No. 10/954,823 filed Sep. 30,2004, which is a division of U.S. application Ser. No. 10/779,014 filed Feb. 13, 2004, which is division of U.S. application Ser. No. 10/072,154 filed Feb. 6,2002 (now U.S. Pat. No. 6,716,393), which is a division of U.S. application Ser. No. 09/444,926 (now U.S. Pat. No. 6,514,461) filed Nov. 24, 1999, which is a Continuation-In-Part of U.S. application Ser. No. 09/245,175 (now U.S. Pat. No. 6,342,183) filed Feb. 5, 1999, and a continuation-in-part of U.S. application Ser. No. 09/025,559 (now U.S. Pat. No. 5,902,982) filed on Feb. 18, 1998, and a continuation-in-part of U.S. application Ser. No. 09/018,487 (now U.S. Pat. No. 6,036,092) filed Feb. 4, 1998, and a continuation in part of U.S. application Ser. No. 08/832,957 (issued as U.S. Pat. No. 5,929,422 and reissued as U.S. Pat. No. RE38,509) filed Apr. 4, 1997, and a continuation in part of U.S. application Ser. No. 08/801,041 (now U.S. Pat. No. 5,916,815) filed Feb. 14, 1997. The disclosures of the aforementioned applications are, by reference, incorporated herein.
1. Field of the Invention
The invention relates to an assaying system. More particularly, the invention relates to a machine readable assaying system for analyzing a specimen of physiological fluid to detect the presence or absence of particular substances therein. In a preferred embodiment, the machine readable assaying system contemplates the utilization of machine readable bar-code patterns imprinted upon a test card which change form in response to a physical, chemical or biological reaction. The test result which is encoded within the bar-code indicia imprinted upon the test card is read by an appropriate decoding apparatus (i.e. a bar-code reader/scanner), and the decoded results are stored in a memory unit and transmitted, if desired, to a distinct location. A test administrator merely scans the bar-code. Because the bar-code patterns change form in such a subtle yet varied manner, the administrator or another observer of the test card is unable to discern the results. Accordingly, the privacy interests of the donor are preserved, as well as human interpretation errors, transcription and translation errors.
The increase in drug use over the past several decades has created a sharp need for more effective, expeditious methods of analyzing whether a particular individual is a user of certain illegal substances. Both private industry employers as well as governmental employers often need to determine whether an individual has drug residue present in his or her biological system, and hence determine whether such an individual is a drug user or drug abuser and thus an unqualified employee.
Typically, the status of an individual as a drug user or abuser is determined by analysis of the individual's physiological fluids, namely urine. A specimen of urine is collected, and a highly sensitive screening test is first performed, usually at a centralized laboratory. If specimen samples screen positive at the central laboratory, then a more sensitive and controlled confirmation analysis must be performed.
In addition to being an extremely costly process, the above mentioned procedure also involves great time delays to employers desirous of obtaining new qualified employees. Upon collection of the urine sample, the employer must wait to receive test results from the central laboratory before hiring any potential employees. Furthermore, the massive amount of handling and transfer of the sample of urine from the initial collection site to the central laboratory.
To combat the above mentioned timeliness problem which faces many employers in awaiting results from the central laboratory, various “on-site” or “hand-held” assaying devices have been developed. A major problem inherent in these “on-site” testing devices is that the privacy concerns of the potential employee being tested are not adequately addressed. Since all of the on-site testing devices available heretofore attempt merely to identify drugs present (i.e. simply to indicate which specimens do indeed possess the prohibited substance/drug), the anonymity of a presumptive positive donor is impossible to conceal. Due to such lack of anonymity, many employers (governmental in particular) will not employ such an assaying system as it does not comply with federally mandated regulations regarding privacy and civil liberties during drug-employment testing. A more anonymous, reliable and expeditious assaying system is needed, wherein negative results can be obtained quickly without compromising the privacy concerns of the tested individual. The results are not “human readable” and thus are not subject to interpretation.
It is an object of the invention to produce an assaying system for analyzing a specimen of body fluid to detect the absence of particular substances therein.
It is another object of the invention to provide an assaying system which provides more anonymous, reliable and expeditious results than those assaying systems presently found in the art, wherein said results can be obtained quickly without compromising the privacy concerns of the tested donor individual.
It is a further object of the invention to provide an on-site, portable assaying system which allows the results of said assay to be determined and utilized almost immediately by an employer, without jeopardizing the privacy rights of the individual being tested.
It is a still further object of the invention to provide an assaying system which allows the results of said assay to be encoded in a machine readable format (such as bar-coding) such that said encoded results are visually undetectable and must be de-coded by appropriate apparatus. Accordingly, the administrator of the assay lacks access to the test results.
It is yet another object of the invention to provide an assaying system which possesses a memory unit to store resultant decoded assay data, and communication means for transmitting said decoded data to a distinct location (such as a central laboratory/processing office). Upon receiving the assay data, the central laboratory/processing office could then electronically, telephonically or manually (via a delivered hard copy) communicate a responsive “negative test certificate” to the employer for those individuals testing negative (indicating that these individuals are candidates for immediate employment). A sample specimen of physiological fluid from only those individuals who tested positive would then be requested by the central laboratory for standard “confirmation” testing.
It is yet another object of the invention to provide an assaying system such as that discussed above which possesses means capable of detecting adulteration of the specimen.
To the accomplishment of the above and related objects the invention may be embodied in the form illustrated in the accompanying drawings. Attention is called to the fact, however, that the drawings are illustrative only. Variations are contemplated as being part of the invention, limited only by the scope of the claims.
As seen in detail in
As seen in the arrangement depicted in
It is contemplated in the preferred embodiment that one or more of the individual analysis strips 34 which comprise the bar code indicia of the machine readable assaying means 32 contain reagents or antibodies whose visual appearance is altered in response to physiological fluid, regardless of whether any illicit drugs are present within said fluid. It is further contemplated that these “control” analysis strips 34C be situated such that their detection amongst the pattern of strips 33A and 34 and blank regions 33B (bars and spaces) comprising the bar code indicia does not vary the character of the information encoded therewithin. For instance, the bar code indicia of the machine readable assaying means 32 would indicate, if decoded by an appropriate device prior to contact with physiological fluid, a negative presence of illicit drugs. Upon contact with a volume of physiological fluid which lacks the presence of illicit drugs, the “control” analysis strips 34C will appear. However, their placement amongst the standard test strips 34, fixed test strips 33A and blank regions 33B will not effect the initial encoded character of the bar code indicia. Accordingly, a negative assay will be determined.
The function of the “control” analysis strips 34 is to prevent an administrator of the test from learning the outcome of the assay. If, subsequent to the administration of each assay, some type of change occurs to the visual appearance of the machine readable assaying means 32, then the test administrator will be unable to discern positive test results from negative results. Only the device used to decode the encoded bar code indicia will be able to determine whether the donor's specimen of physiological fluid tests positive for illicit drugs, and if so, which particular substances were present.
The test card 22 of
Further included upon the test card 22 of
Also seen in
Turning now to
One possible embodiment of the test card reading apparatus 60 is seen in
It should be noted that the controller module 62 may be provided by known programmable single chip microcomputers and any additional analog/digital circuitry required. Further, it is contemplated that the controller module 62 may be provided (in an alternate embodiment to that shown in
Another embodiment of the test card reading unit 54 of
The aforementioned configuration of the machine readable assaying system of the instant invention render said system capable of being employed on-site at an employer's individual location. A donor individual is given a collection container and provided a private environment where said donor individual is to excrete a specimen volume of urine into the collection container for analysis. A volume of urine is then brought into contact with the test card 22 (by bathing the test card 22 with a small amount of urine, inserting the test card 22 into the urine, etc.) The quality control indication means 38 and/or the control test strips 34 are then checked to assure the integrity of the assaying means 32. Assuming that the assay is functioning properly, the adulteration detection means 36 are then checked to determined whether the donor individual tampered with the specimen. If the adulteration detection means 36 indicate that the specimen is unadulterated, then the machine readable assaying means 32 are then read by the test card reading unit 54 (such as the scanner 54 a and decoder 54 b). The results of the assay are then stored in the memory unit 62B of the controller module 62 for transmission to a desired location such as the centralized laboratory 58.
Upon the central laboratory 58 receiving the assay data, the names or identification codes of those donor individuals who provided negative results may be immediately communicated to prospective employers, so that those particular donors may be offered employment. All positive assay urine specimens will be requested from the test site by the central laboratory 58 for further confirmation analysis. Accordingly, the employer is immediately provided with a number of qualified potential employees to choose from, and the privacy concerns of the donor individual are safeguarded.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3832134 *||Oct 4, 1971||Aug 27, 1974||D Sohn||Tlc method and device for detecting the presence of target substances in unknown solutions|
|US3849256 *||Oct 13, 1972||Nov 19, 1974||F Linder||Substrate-containing test container|
|US3980436 *||Dec 19, 1974||Sep 14, 1976||Sci-Med Laboratories, Inc.||Analytic test device|
|US4040791 *||Jun 22, 1976||Aug 9, 1977||David H Kuntz||Specimen collecting device|
|US4042329 *||Apr 14, 1976||Aug 16, 1977||Becton, Dickinson And Company||Method and device for detecting cholesterol|
|US4059407 *||Jan 12, 1977||Nov 22, 1977||Becton, Dickinson And Company||Disposable chemical indicators|
|US4070249 *||Jun 8, 1976||Jan 24, 1978||American Home Products Corporation||Apparatus for compensating for pressure within a biological test device|
|US4385115 *||Oct 22, 1980||May 24, 1983||Hoffmann-La Roche Inc.||Diagnostics testing devices and processes|
|US4435504 *||Jul 15, 1982||Mar 6, 1984||Syva Company||Immunochromatographic assay with support having bound "MIP" and second enzyme|
|US4454235 *||Jun 1, 1982||Jun 12, 1984||Miles Laboratories, Inc.||Capillary tube holder for liquid transfer in immunoassay|
|US4458020 *||Nov 15, 1982||Jul 3, 1984||Quidel||Integrated single tube plunger immunoassay system having plural reagent chambers|
|US4473530 *||Sep 24, 1980||Sep 25, 1984||Villa Real Antony Euclid C||Compact sanitary urinalysis unit|
|US4557274 *||Dec 2, 1983||Dec 10, 1985||Cawood Charles David||Midstream urine collector|
|US4573983 *||Jul 27, 1984||Mar 4, 1986||The Kendall Company||Liquid collection system having an anti-septic member on the discharge section|
|US4624929 *||Dec 3, 1984||Nov 25, 1986||Syntex (U.S.A.) Inc.||Sample collector and assay device and method for its use|
|US4690801 *||Jun 3, 1986||Sep 1, 1987||Allelix Inc.||Device for performing enzyme immunoassays|
|US4783193 *||Nov 3, 1986||Nov 8, 1988||Laury Pensa||Composition and process for stripping color from synthetic polymer products|
|US4789638 *||May 6, 1987||Dec 6, 1988||Kramer David N||Process and apparatus for the detection of hydrazine and hydrazine derivatives|
|US4842826 *||Apr 6, 1987||Jun 27, 1989||Sta.Te. S.P.A.||Disposable device for collecting physiological samples, in particular coprological samples|
|US4844866 *||Nov 13, 1984||Jul 4, 1989||Matrix Technologies, Inc.||Carrier for detecting drug abuse compounds|
|US4865813 *||Jul 7, 1986||Sep 12, 1989||Leon Luis P||Disposable analytical device|
|US4885253 *||Mar 27, 1989||Dec 5, 1989||Steris Corporation||Universal biological indicator system|
|US4920046 *||Oct 8, 1987||Apr 24, 1990||Becton, Dickinson And Company||Process, test device, and test kit for a rapid assay having a visible readout|
|US4927605 *||Apr 22, 1987||May 22, 1990||Wadley Technologies, Inc.||Specimen collection and sampling container|
|US4953561 *||Sep 22, 1989||Sep 4, 1990||Cancer Diagnostics, Inc.||Urine testing module and method of collecting urine antigen|
|US4960130 *||Nov 14, 1989||Oct 2, 1990||Cancer Diagnostics, Inc.||Modular fluid sample preparation assembly|
|US4961432 *||Jan 10, 1989||Oct 9, 1990||Cancer Diagnostics, Inc.||Modular fluid sample preparation assembly|
|US4976923 *||May 12, 1989||Dec 11, 1990||Rhode Island Hospital||Sample container|
|US4978502 *||Dec 15, 1987||Dec 18, 1990||Dole Associates, Inc.||Immunoassay or diagnostic device and method of manufacture|
|US4992296 *||Feb 24, 1989||Feb 12, 1991||Gibson Jacob J||Abuse-type drug test papers and methods of making and using same|
|US5003988 *||Aug 22, 1989||Apr 2, 1991||La Mina Ltd.||Modular multiple fluid sample preparation assembly|
|US5009235 *||Aug 16, 1989||Apr 23, 1991||Messenheimer Ronald L||Urine specimen collecting method using a vehicle|
|US5016644 *||Sep 25, 1989||May 21, 1991||La Mina Ltd.||Urine testing module and method of collecting urine antigen|
|US5022411 *||Nov 22, 1989||Jun 11, 1991||La Mina Ltd.||Modular fluid testing device|
|US5024237 *||Jun 21, 1989||Jun 18, 1991||La Mina Ltd.||Modular fluid sample preparation assembly|
|US5039616 *||Aug 31, 1989||Aug 13, 1991||Copelan Herbert W||Method for prevention of specimen tampering in substance abuse testing and test area relating thereto|
|US5119830 *||Apr 3, 1991||Jun 9, 1992||Code Blue Medical Corporation||Analytical specimen cup with testing means|
|US5133935 *||Jul 29, 1991||Jul 28, 1992||Copelan Herbert W||Test area for prevention of specimen tampering in substance abuse testing|
|US5149505 *||Jul 18, 1989||Sep 22, 1992||Abbott Laboratories||Diagnostic testing device|
|US5186897 *||Apr 11, 1990||Feb 16, 1993||Ares-Serono Research & Development Limited Partnership||Multianalyte test vehicle|
|US5200321 *||Sep 7, 1990||Apr 6, 1993||The United States Of America As Represented By The Secretary Of The Navy||Microassay on a card|
|US5215102 *||Oct 25, 1991||Jun 1, 1993||La Mina Ltd.||Capillary blood antigen testing apparatus|
|US5283038 *||Oct 11, 1991||Feb 1, 1994||Saliva Diagnostic Systems, Inc.||Fluid sampling and testing device|
|US5316732 *||Jul 1, 1992||May 31, 1994||Smithkline Diagnostics, Inc.||Extraction vial|
|US5320808 *||Aug 2, 1988||Jun 14, 1994||Abbott Laboratories||Reaction cartridge and carousel for biological sample analyzer|
|US5356782 *||Sep 3, 1992||Oct 18, 1994||Boehringer Mannheim Corporation||Analytical test apparatus with on board negative and positive control|
|US5403551 *||Sep 16, 1993||Apr 4, 1995||Roche Diagnostic Systems, Inc.||Assaying device and container for in field analysis of a specimen and later shipment of the unadulterated specimen|
|US5408535 *||Sep 7, 1993||Apr 18, 1995||Miles Inc.||Video test strip reader and method for evaluating test strips|
|US5429803 *||Apr 18, 1991||Jul 4, 1995||Lamina, Inc.||Liquid specimen container and attachable testing modules|
|US5429804 *||Jul 15, 1994||Jul 4, 1995||Sayles; Philip W.||One-step testing device|
|US5464775 *||Jul 27, 1994||Nov 7, 1995||Chimera Research And Chemical, Inc.||Method of detecting adulterant in urine|
|US5490971 *||Oct 25, 1994||Feb 13, 1996||Sippican, Inc.||Chemical detector|
|US5496736 *||May 17, 1995||Mar 5, 1996||Hybrivet Systems, Inc.||Process for testing for substances in liquids|
|US5501837 *||Jun 30, 1995||Mar 26, 1996||Sayles; Philip W.||One-step test device|
|US5508200 *||Oct 19, 1992||Apr 16, 1996||Tiffany; Thomas||Method and apparatus for conducting multiple chemical assays|
|US5516638 *||Jun 27, 1994||May 14, 1996||Calypte, Inc.||Immunoassays for the detection of antibodies to Chlamydia trachomatisi in the urine.|
|US5541059 *||Dec 29, 1993||Jul 30, 1996||Chu; Albert E.||Immunoassay device having an internal control of protein A and methods of using same|
|US5591401 *||Mar 25, 1996||Jan 7, 1997||Sayles; Philip W.||One-step test device|
|US5603903 *||Dec 18, 1995||Feb 18, 1997||Copelan; Herbert W.||Specimen-container holder apparatus to prevent cross contamination|
|US5640969 *||May 16, 1995||Jun 24, 1997||Urocath Corporation||Lid for an analytical specimen cup|
|US5770458 *||Jun 17, 1997||Jun 23, 1998||Roche Diagnostics Systems, Inc.||Apparatus and method for conducting a binding assay on an absorbant carrier material|
|US5849505 *||Jun 7, 1995||Dec 15, 1998||Lamina, Inc.||Liquid specimen container and attachable testing modules|
|US5850468 *||Jan 16, 1998||Dec 15, 1998||Matsushita Electric Industrial Co., Ltd.||Flaw detection apparatus|
|US5902982 *||Feb 18, 1998||May 11, 1999||National Medical Review Office Inc.||Changeable machine readable assaying indicia|
|US5929422 *||Apr 4, 1997||Jul 27, 1999||National Medical Review Office Inc.||On-site Machine readable assaying system|
|US5942407 *||Jun 25, 1997||Aug 24, 1999||Immunomatrix, Inc.||Light-emitting immunoassay|
|US5976895 *||Mar 11, 1996||Nov 2, 1999||American Biomedica Corporation||Device for the collection, testing and shipment of body fluid samples|
|US5989924 *||Sep 30, 1997||Nov 23, 1999||Becton, Dickinson And Company||Device for determining an analyte in a sample|
|US6074606 *||Oct 19, 1998||Jun 13, 2000||Sayles; Philip W.||One-step test device|
|US6097831 *||Oct 14, 1997||Aug 1, 2000||Chiron Corporation||Non-contract method for assay reagent volume dispense verification|
|US6184040 *||Jan 27, 1999||Feb 6, 2001||Polaroid Corporation||Diagnostic assay system and method|
|US6770487 *||May 1, 2001||Aug 3, 2004||Ischemia Technologies, Inc.||Bar code readable diagnostic strip test|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7943381||Oct 27, 2006||May 17, 2011||Escreen, Inc.||Method for testing specimens located at a plurality of service sites|
|US20110213564 *||Sep 1, 2011||Henke Tom L||Method and apparatus for code verified testing|
|WO2013163353A1 *||Apr 24, 2013||Oct 31, 2013||Arizona Board Of Regents, Acting For And On Behalf Of Northern Arizona University||Rapid multiplex lateral flow assay device|
|U.S. Classification||435/7.1, 702/19|
|International Classification||G01N1/00, G01N35/10, G01N33/52, G06K19/06, B01L3/00, G01N33/94, G01N21/27, G01N33/487, G01N21/78, G01N31/22, G01N1/10, G06K19/10, G06F19/00, G01N33/53, G01N33/50, G01N33/543, G01N33/48|
|Cooperative Classification||G06K9/00154, G06Q30/018, Y10T436/13, Y10T436/25, B01L2300/0832, G06F19/3418, G06K2019/06253, B01L2400/0683, B01L2300/021, G01N35/00871, B01L3/502, G01N33/54366, B01L3/502715, G06K19/10, G01N33/94, B01L2300/0825, B01L2400/0478, B01L2300/025, B01L2300/069, B01L2400/0406, B01L2200/141, B01L2300/042, B01L2200/0605, G01N33/528, B01L2300/046, G06F19/3406, G06F19/366, B01L2300/0663, B01L3/545, B01L2300/047, G06Q50/22|
|European Classification||G01N33/94, G01N33/52D, G06K19/10, G01N35/00G3L, G06F19/36C, B01L3/502, B01L3/5027B, B01L3/545, G01N33/543K|
|Feb 8, 2008||AS||Assignment|
Owner name: BANK OF AMERICA, N.A.,ILLINOIS
Free format text: SECURITY AGREEMENT;ASSIGNOR:ESCREEN, INC;REEL/FRAME:020485/0718
Effective date: 20080131
|May 19, 2010||AS||Assignment|
Owner name: ESCREEN, INC.,KANSAS
Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:024411/0022
Effective date: 20100519
Owner name: ESCREEN, INC., KANSAS
Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BANK OF AMERICA, N.A.;REEL/FRAME:024411/0022
Effective date: 20100519